Sandra Lord

49PUBLICATIONS
166CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutrigenomics and personalised nutritionMetabolic medicineInformation systems development methodologies and practiceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jan 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum, S Alice Long, Stephen E Gitelman

|Aug 25, 2025
Lessons from Prediction and Prevention of Type 1 Diabetes.

Cate Speake, Adam Lacy-Hulbert, James Lord

|Feb 11, 2025
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Moshe Phillip, Peter Achenbach, Ananta Addala

|Sep 04, 2024
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.

Moshe Phillip, Peter Achenbach, Ananta Addala

|Aug 21, 2024
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.

Carla J Greenbaum, Gerald T Nepom, Lauren K Wood-Heickman

|Jun 24, 2024
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.

Moshe Phillip, Peter Achenbach, Ananta Addala

Pageof 9

Frequent Collaborators

18 joint publications

Cate Speake

14 joint publications

Kevan C Herold

10 joint publications

Andrea K Steck

9 joint publications

Emily K Sims